Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issaka Zongo

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
BMC Medicine|October 6, 2022
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01<sub>E</sub> vaccination and seasonal malaria chemoprevention versus either intervention given aloneMatthew Cairns, Amadou Barry, Issaka Zongo, et al.
Malaria Journal|August 27, 2011
Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasitesMahamadou Diakite, Eric A Achidi, Olivia Achonduh, et al.
The Journal of Infectious Diseases|June 21, 2014
Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolatesHarold Ocholla, Mark D Preston, Mwapatsa Mipando, et al.
Nature Communications|June 14, 2014
A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strainsMark D Preston, Susana Campino, Samuel A Assefa, et al.
Malaria Journal|February 23, 2022
Impact of seasonal RTS,S/AS01<sub>E</sub> vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and MaliJane Grant, Issaka Sagara, Issaka Zongo, et al.
Plos Medicine|January 11, 2017
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-AnalysisRichard M Hoglund, Lesley Workman, Michael D Edstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria VaccineIssaka Sagara, Issaka Zongo, Matthew Cairns, et al.
The New England Journal of Medicine|August 25, 2021
Seasonal Malaria Vaccination with or without Seasonal Malaria ChemopreventionDaniel Chandramohan, Issaka Zongo, Issaka Sagara, et al.
Plos One|June 16, 2011
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assaySusana Campino, Sarah Auburn, Katja Kivinen, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2021
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina FasoKhalid B Beshir, Nouhoum Diallo, Fabrice A Somé, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
BMC Medicine|October 6, 2022
The duration of protection against clinical malaria provided by the combination of seasonal RTS,S/AS01<sub>E</sub> vaccination and seasonal malaria chemoprevention versus either intervention given aloneMatthew Cairns, Amadou Barry, Issaka Zongo, et al.
Malaria Journal|August 27, 2011
Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasitesMahamadou Diakite, Eric A Achidi, Olivia Achonduh, et al.
The Journal of Infectious Diseases|June 21, 2014
Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolatesHarold Ocholla, Mark D Preston, Mwapatsa Mipando, et al.
Nature Communications|June 14, 2014
A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strainsMark D Preston, Susana Campino, Samuel A Assefa, et al.
Malaria Journal|February 23, 2022
Impact of seasonal RTS,S/AS01<sub>E</sub> vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and MaliJane Grant, Issaka Sagara, Issaka Zongo, et al.
Plos Medicine|January 11, 2017
Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-AnalysisRichard M Hoglund, Lesley Workman, Michael D Edstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 11, 2021
The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria VaccineIssaka Sagara, Issaka Zongo, Matthew Cairns, et al.
The New England Journal of Medicine|August 25, 2021
Seasonal Malaria Vaccination with or without Seasonal Malaria ChemopreventionDaniel Chandramohan, Issaka Zongo, Issaka Sagara, et al.
Plos One|June 16, 2011
Population genetic analysis of Plasmodium falciparum parasites using a customized Illumina GoldenGate genotyping assaySusana Campino, Sarah Auburn, Katja Kivinen, et al.
Antimicrobial Agents and Chemotherapy|June 1, 2021
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina FasoKhalid B Beshir, Nouhoum Diallo, Fabrice A Somé, et al.
Pageof 7